Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study

Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study

<b>Background/Objectives:</b> The current research examines the accuracy of α-synuclein in RBCs as a diagnostic biomarker for PD and PSP, despite their distinct molecular etiologies. <b>Methods:</b> We used ELISA to measure total, oligomeric, and p129-α-synuclein levels in er...

Full description

Saved in:

Bibliographic Details
Main Authors:	Costanza Maria Cristiani, Luana Scaramuzzino, Elvira Immacolata Parrotta, Giovanni Cuda, Aldo Quattrone, Andrea Quattrone
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Biomedicines
Subjects:	Parkinson’s disease progressive supranuclear palsy α-synuclein oligomeric α-synuclein phosphorylated α-synuclein red blood cells
Online Access:	https://www.mdpi.com/2227-9059/12/11/2510
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study
by: Costanza Maria Cristiani, et al.
Published: (2024-12-01)

c-Abl Inhibitors in Parkinson’s: Exploring Hypotheses on Alpha-Synuclein Modulation
by: Jyutia Nargish, et al.
Published: (2025-04-01)

Pilot Study of [<sup>11</sup>C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer
by: Chia-Ju Hsieh, et al.
Published: (2025-07-01)

Serine-129 phosphorylated α-synuclein drives mitochondrial dysfunction and calcium dysregulation in Parkinson’s disease model
by: Jie Jiao, et al.
Published: (2025-03-01)

Bridging the gap: investigating the role of phosphorylation at the serine 129 site of α-synuclein in VAPB-PTPIP51 interactions
by: Weijin Liu, et al.
Published: (2025-02-01)

The interplay of iron, oxidative stress, and α-synuclein in Parkinson’s disease progression
by: Yan Chen, et al.
Published: (2025-04-01)

α-synuclein fibrils per se but not α-synuclein seeded aggregation causes mitochondrial dysfunction and cell death in human neurons
by: Plamena R. Angelova, et al.
Published: (2025-10-01)

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01)

USP14 is crucial for proteostasis regulation and α-synuclein degradation in human SH-SY5Y dopaminergic cells
by: Vignesh Srinivasan, et al.
Published: (2025-02-01)

Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability
by: Elena A. Ostrakhovitch, et al.
Published: (2025-05-01)

Tet2 loss and enhanced ciliogenesis suppress α-synuclein pathology
by: Emmanuel Quansah, et al.
Published: (2025-04-01)

Resolving acetylated and phosphorylated proteins by neutral urea Triton-polyacrylamide gel electrophoresis: NUT-PAGE
by: Christopher J. Buehl, et al.
Published: (2014-08-01)

Parkinson’s Disease: A Narrative of the Evolving Understanding of the Role of α-Synuclein in Screening
by: Alan D. Kaye, et al.
Published: (2024-11-01)

Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01)

A fragment of Calpain-1 cleaved α-Synuclein quantified in serum is upregulated in patients with Parkinson’s disease
by: Signe Holm Nielsen, et al.
Published: (2025-04-01)

α-Synuclein ubiquitination – functions in proteostasis and development of Lewy bodies
by: Hung-Hsiang Ho, et al.
Published: (2024-11-01)

A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage
by: Silvia Zini, et al.
Published: (2025-09-01)

α‐Synuclein Pathology Spreads in a Midbrain–Hindbrain Assembloid Model
by: Gemma Gomez‐Giro, et al.
Published: (2025-05-01)

Nanotherapeutic Approaches of Interleukin‐3 to Clear the α‐Synuclein Pathology in Mouse Models of Parkinson's Disease
by: Wenlong Zhang, et al.
Published: (2024-11-01)

The Parkinson’s disease-associated protein α-synuclein disrupts stress signaling – a possible implication for methamphetamine use?
by: Shaoxiao Wang, et al.
Published: (2014-03-01)

Intact microdissection of stellate ganglia in a Parkinson's disease model reveals aggregation of mutant human α‐synuclein in their cell bodies
by: Bonn Lee, et al.
Published: (2025-06-01)

Unraveling the mystery: How autophagy deficiency in dopaminergic neurons drives human Parkinson’s disease
by: Sachiko Noda, et al.
Published: (2025-07-01)

Serum α-Synuclein in Pediatric Refractory Epilepsy: Correlation with Diagnosis and Clinical Severity
by: Aida M. S. Salem, et al.
Published: (2025-04-01)

Early α-synuclein aggregation decreases corticostriatal glutamate drive and synapse density
by: Charlotte F. Brzozowski, et al.
Published: (2025-06-01)

Experimental and computational insights into the therapeutic mechanisms of resveratrol in a Drosophila α-synuclein model of Parkinson’s disease
by: Amos Olalekan Abolaji, et al.
Published: (2025-05-01)

Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson’s Disease
by: Lydia Shen, et al.
Published: (2024-12-01)

α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies
by: Francisco J. Padilla-Godínez, et al.
Published: (2025-03-01)

Renalase Overexpression-Mediated Excessive Metabolism of Peripheral Dopamine, DOPAL Accumulation, and α-Synuclein Aggregation in Baroreflex Afferents Contribute to Neuronal Degeneration and Autonomic Dysfunction
by: Xue Xiong, et al.
Published: (2025-05-01)

Altered reactivity to threatening stimuli in Drosophila models of Parkinson’s disease, revealed by a trial-based assay
by: Márton Kajtor, et al.
Published: (2025-07-01)

TUDCA combined with Syndopa protects the midbrain and gut from MPTP toxicity in a Parkinson’s disease mouse model: Immunohistochemical evidence
by: Mahalakshmi Rajan, et al.
Published: (2025-08-01)

Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
by: Filip Fredlund, et al.
Published: (2025-04-01)

Discovery of <i>N</i>-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson’s Disease with Positron Emission Tomography
by: Haiyang Zhao, et al.
Published: (2025-07-01)

Astrocyte alterations in α-synucleinopathies
by: Manuela Rodríguez-Castañeda, et al.
Published: (2025-08-01)

Intracellular Inclusions Induced by Patient-Derived and Amplified α-Synuclein Aggregates Are Morphologically Indistinguishable
by: Rabab Al-Lahham, et al.
Published: (2025-05-01)

Photochemically synthesized gold nanoparticles conjugated with Boswellic acid inhibit alpha synuclein aggregation and delay fibrillation kinetics
by: Masoumeh Gharb, et al.
Published: (2025-07-01)

The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity
by: Daniel Torrente, et al.
Published: (2025-01-01)

Binding of α-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson's disease models
by: Jie Jiao, et al.
Published: (2024-11-01)

Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
by: Irene Sambri, et al.
Published: (2016-11-01)

LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies
by: Marc Emmenegger, et al.
Published: (2021-07-01)

The effects of melatonin and catalase supplements on the survival of α-Synuclein-expressing saccharomyces cerevisiae cells.
by: Laura Houghton
Published: (2023-08-01)